0001209191-15-019935.txt : 20150228 0001209191-15-019935.hdr.sgml : 20150227 20150227185330 ACCESSION NUMBER: 0001209191-15-019935 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20150227 FILED AS OF DATE: 20150227 DATE AS OF CHANGE: 20150227 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Mylan N.V. CENTRAL INDEX KEY: 0001623613 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 981189497 STATE OF INCORPORATION: P7 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ALBANY GATE, DARKES LANE CITY: POTTERS BAR, HERTS STATE: X0 ZIP: EN6 1AG BUSINESS PHONE: 44 0 1707 853 000 MAIL ADDRESS: STREET 1: ALBANY GATE, DARKES LANE CITY: POTTERS BAR, HERTS STATE: X0 ZIP: EN6 1AG FORMER COMPANY: FORMER CONFORMED NAME: Mylan B.V. DATE OF NAME CHANGE: 20150227 FORMER COMPANY: FORMER CONFORMED NAME: New Moon B.V. DATE OF NAME CHANGE: 20141028 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cindrich Robert J CENTRAL INDEX KEY: 0001514036 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 333-199861 FILM NUMBER: 15661455 MAIL ADDRESS: STREET 1: 1500 CORPORATE DRIVE CITY: CANONSBURG STATE: PA ZIP: 15317 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2015-02-27 1 0001623613 Mylan N.V. MYL 0001514036 Cindrich Robert J ALBANY GATE, DARKES LANE POTTERS BAR, HERTFORDSHIRE X0 EN6 1AG UNITED KINGDOM 1 0 0 0 On February 27, 2015 (the "Closing Date"), Mylan N.V. completed the transaction (the "Transaction") by which it acquired Mylan Inc. and Abbott Laboratories' ("Abbott") non-U.S. developed markets specialty and branded generics business (the "Business"). Pursuant to the terms of the Amended and Restated Business Transfer Agreement and Plan of Merger, dated as of November 4, 2014, by and among Mylan Inc., New Moon B.V. (which has been renamed Mylan N.V. and is referred to herein as "Mylan"), Moon of PA Inc. ("Merger Sub"), and Abbott, on the Closing Date, Mylan acquired the Business and Merger Sub merged with and into Mylan Inc., with Mylan Inc. surviving as a wholly owned indirect subsidiary of Mylan and each share of Mylan Inc. common stock issued and outstanding was cancelled and automatically converted into and became the right to receive one Mylan ordinary share. In connection with the Transaction, Mylan Inc. and the Business have been reorganized under Mylan, a new public company organized in the Netherlands. This report reflects the beneficial ownership of the reporting person at the time of the consummation of the Transaction and does not include the securities of Mylan acquired by the reporting person upon the consummation of the Transaction. The reporting person will file a Form 4 reflecting his acquisition of Mylan securities in connection with the consummation of the Transaction. Exhibit 24 - Power of Attorney /s/ Bradley L. Wideman, by power of attorney 2015-02-27 EX-24 2 attachment1.htm EX-24 DOCUMENT

                                POWER OF ATTORNEY

        The undersigned hereby appoints each of Joseph F. Haggerty, Mark Nance,
and Bradley L. Wideman, or any of them signing singly, and with full power of
substitution, the undersigned's true and lawful attorney-in-fact to:

        (1)     prepare, execute in the undersigned's name and on the
                undersigned's behalf, and submit to the U.S. Securities and
                Exchange Commission (the "SEC") a Form ID, including amendments
                thereto, and any other documents necessary or appropriate to
                obtain codes and passwords enabling the undersigned to make
                electronic filings with the SEC of reports required by Section
                16(a) of the Securities Exchange Act of 1934, as amended (the
                "Exchange Act"), or any rule or regulation of the SEC;

        (2)     execute for and on behalf of the undersigned, in the
                undersigned's capacity as an officer and/or director of Mylan
                N.V. (the "Company"), Forms 3, 4, and 5 in accordance with
                Section 16(a) of the Exchange Act, and the rules thereunder;

        (3)     do and perform any and all acts for and on behalf of the
                undersigned which may be necessary or desirable to complete and
                execute any such Form 3, 4, or 5, complete and execute any
                amendment or amendments thereto, and timely file such form with
                the SEC and any stock exchange or similar authority; and

        (4)     take any other action of any type whatsoever in connection with
                the foregoing which, in the opinion of such attorney-in-fact,
                may be of benefit to, in the best interest of, or legally
                required by, the undersigned, it being understood that the
                documents executed by such attorney-in-fact on behalf of the
                undersigned pursuant to this Power of Attorney shall be in such
                form and shall contain such terms and conditions as such
                attorney-in-fact may approve in such attorney-in-fact's
                discretion.

        The undersigned hereby grants to each such attorney-in-fact full power
and authority to do and perform any and every act and thing whatsoever
requisite, necessary, or proper to be done in the exercise of any of the rights
and powers herein granted, as fully to all intents and purposes as the
undersigned might or could do if personally present, with full power of
substitution or revocation, hereby ratifying and confirming all that such
attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall
lawfully do or cause to be done by virtue of this power of attorney and the
rights and powers herein granted. The undersigned acknowledges that the
foregoing attorneys-in-fact, in serving in such capacity at the request of the
undersigned, are not assuming, nor is the Company assuming, any of the
undersigned's responsibilities to comply with Section 16 of the Exchange Act.

        This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4, and 5 with respect to the
undersigned's holdings of and transactions in securities issued by the Company,
unless earlier revoked by the undersigned in a signed writing delivered to the
foregoing attorneys-in-fact.

        IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to
be executed as of this 27th day of February, 2015.

                                                /s/ Robert J. Cindrich
                                        ----------------------------------------
                                                   Signature

                                                Robert J. Cindrich
                                        ----------------------------------------
                                                   Print Name